Citi Starts Intellia Therapeutics (NTLA) at Sell
Tweet
Share
E-mailGet Alerts NTLA Hot Sheet
Price: $11.83 -2.15%
Rating Summary:
23 Buy, 9 Hold, 3 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 19 | Down: 16 | New: 9
Rating Summary:
23 Buy, 9 Hold, 3 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 19 | Down: 16 | New: 9
Join SI Premium – FREE
Citi analyst David Lebowitz initiates coverage on Intellia Therapeutics (NASDAQ: NTLA) with a Sell rating and a price target of $50.00.
For an analyst ratings summary and ratings history on Intellia Therapeutics click here. For more ratings news on Intellia Therapeutics click here.
Shares of Intellia Therapeutics closed at $60.06 yesterday.
You May Also Be Interested In
- Lake Street Starts RF Industries Ltd. (RFIL) at Buy
- Piper Sandler Starts Jasper Therapeutics (JSPR) at Overweight
- Alliance Global Partners Starts Momentus (MNTS) at Buy
Create E-mail Alert Related Categories
New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
